ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 639 filers reported holding ASTRAZENECA PLC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,169 | +15.2% | 14,983 | 0.0% | 0.20% | +12.0% |
Q1 2024 | $1,015 | -0.9% | 14,983 | -1.5% | 0.18% | -9.3% |
Q4 2023 | $1,024 | -2.1% | 15,210 | -1.5% | 0.19% | -10.6% |
Q3 2023 | $1,046 | -8.9% | 15,448 | -3.7% | 0.22% | -9.6% |
Q2 2023 | $1,148 | +0.7% | 16,043 | -2.3% | 0.24% | -5.5% |
Q1 2023 | $1,140 | +0.6% | 16,421 | -1.7% | 0.25% | +3.7% |
Q4 2022 | $1,133 | -99.9% | 16,713 | -4.6% | 0.24% | -1.6% |
Q3 2022 | $961,000 | -19.6% | 17,519 | -3.1% | 0.25% | -15.1% |
Q2 2022 | $1,195,000 | -14.1% | 18,086 | -13.7% | 0.29% | -2.3% |
Q1 2022 | $1,391,000 | +8.0% | 20,965 | -5.2% | 0.30% | +8.3% |
Q4 2021 | $1,288,000 | -3.7% | 22,107 | -0.7% | 0.28% | -10.7% |
Q3 2021 | $1,337,000 | -0.7% | 22,261 | -9.4% | 0.31% | -23.1% |
Q2 2021 | $1,347,000 | +12.2% | 24,580 | +1.8% | 0.40% | +44.6% |
Q1 2021 | $1,200,000 | -0.5% | 24,141 | +0.1% | 0.28% | -7.3% |
Q4 2020 | $1,206,000 | -10.5% | 24,121 | -1.9% | 0.30% | -25.4% |
Q3 2020 | $1,347,000 | -2.0% | 24,580 | -5.4% | 0.40% | -7.6% |
Q2 2020 | $1,374,000 | +13.7% | 25,978 | -4.0% | 0.44% | +5.8% |
Q1 2020 | $1,208,000 | -16.7% | 27,056 | -7.0% | 0.41% | -1.2% |
Q4 2019 | $1,450,000 | +9.2% | 29,083 | -2.4% | 0.42% | +0.7% |
Q3 2019 | $1,328,000 | +2.9% | 29,798 | -4.7% | 0.41% | +1.0% |
Q2 2019 | $1,291,000 | -0.9% | 31,278 | -2.9% | 0.41% | -4.7% |
Q1 2019 | $1,303,000 | +6.8% | 32,228 | +0.3% | 0.43% | -2.7% |
Q4 2018 | $1,220,000 | -10.2% | 32,133 | -6.4% | 0.44% | +3.8% |
Q3 2018 | $1,359,000 | +12.3% | 34,346 | -0.3% | 0.42% | +6.8% |
Q2 2018 | $1,210,000 | -3.4% | 34,461 | -3.8% | 0.40% | +2.6% |
Q1 2018 | $1,253,000 | +9.5% | 35,831 | +8.7% | 0.39% | +1.8% |
Q4 2017 | $1,144,000 | +2.4% | 32,960 | 0.0% | 0.38% | -2.3% |
Q3 2017 | $1,117,000 | -1.4% | 32,960 | -0.8% | 0.39% | -6.9% |
Q2 2017 | $1,133,000 | +10.4% | 33,235 | +0.9% | 0.42% | +1.9% |
Q1 2017 | $1,026,000 | -99.9% | 32,950 | +3.8% | 0.41% | +9.6% |
Q4 2016 | $867,328,000 | +81415.8% | 31,747 | -1.9% | 0.38% | -24.1% |
Q3 2016 | $1,064,000 | +6.7% | 32,365 | -2.0% | 0.49% | +9.3% |
Q2 2016 | $997,000 | +5.2% | 33,010 | -1.9% | 0.45% | +5.4% |
Q1 2016 | $948,000 | -18.0% | 33,660 | -1.1% | 0.43% | -18.3% |
Q4 2015 | $1,156,000 | +6.7% | 34,040 | 0.0% | 0.52% | +0.8% |
Q3 2015 | $1,083,000 | -7.0% | 34,040 | +86.3% | 0.52% | +4.8% |
Q2 2015 | $1,164,000 | -7.4% | 18,270 | -0.6% | 0.50% | -6.4% |
Q1 2015 | $1,257,000 | -3.2% | 18,375 | -0.4% | 0.53% | -4.8% |
Q4 2014 | $1,299,000 | -1.4% | 18,455 | 0.0% | 0.56% | -6.5% |
Q3 2014 | $1,318,000 | -4.4% | 18,455 | -0.5% | 0.60% | -6.0% |
Q2 2014 | $1,379,000 | +14.5% | 18,555 | 0.0% | 0.64% | +12.0% |
Q1 2014 | $1,204,000 | +9.3% | 18,555 | 0.0% | 0.57% | +7.2% |
Q4 2013 | $1,102,000 | +32.0% | 18,555 | +15.5% | 0.53% | +25.1% |
Q3 2013 | $835,000 | +52.7% | 16,070 | +39.1% | 0.42% | +41.5% |
Q2 2013 | $547,000 | – | 11,555 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |